BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
BLCM
Delisted
BLCM was delisted on the 1st of June, 2023.
84 hedge funds and large institutions have $216M invested in Bellicum Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 19 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
36% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 33
86% less call options, than puts
Call options by funds: $354K | Put options by funds: $2.48M
Holders
84
Holding in Top 10
1
Calls
$354K
Puts
$2.48M
Top Buyers
| 1 | +$6.2M | |
| 2 | +$2.66M | |
| 3 | +$1.69M | |
| 4 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$1.14M |
| 5 |
Goldman Sachs
New York
|
+$1.11M |
Top Sellers
| 1 | -$8.04M | |
| 2 | -$6.14M | |
| 3 | -$5.43M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$4.81M |
| 5 |
QF
QVT Financial
New York
|
-$3.71M |